Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators

被引:5
|
作者
Malosh, Chrysa [1 ,2 ,3 ,4 ]
Turlington, Mark [1 ,2 ,3 ,4 ]
Bridges, Thomas M. [1 ,2 ,3 ]
Rook, Jerri M. [1 ,2 ,3 ]
Noetzel, Meredith J. [1 ,2 ,3 ]
Vinson, Paige N. [1 ,2 ,3 ]
Steckler, Thomas [5 ]
Lavreysen, Hilde [5 ]
Mackie, Claire [6 ]
Bartolome-Nebreda, Jose M. [7 ]
Conde-Ceide, Susana [7 ]
Martinez-Viturro, Carlos M. [7 ]
Piedrafita, Maria [7 ]
Sanchez-Casado, M. Rosa [7 ]
Macdonald, Gregor J. [5 ]
Daniels, J. Scott [1 ,2 ,3 ]
Jones, Carrie K. [1 ,2 ,3 ]
Niswender, Colleen M. [1 ,2 ,3 ]
Conn, P. Jeffrey [1 ,2 ,3 ]
Lindsley, Craig W. [1 ,2 ,3 ,4 ]
Stauffer, Shaun R. [1 ,2 ,3 ,4 ]
机构
[1] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Specialized Chem Ctr Probe Dev MLPCN, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA
[5] Janssen Res & Dev, Neurosci, B-2340 Beerse, Belgium
[6] Janssen Res & Dev, Discovery Sci ADME Tox, Toledo 45007, Spain
[7] Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain
关键词
Metabotropic glutamate receptor 5 (mGlu(5)); Positive allosteric modulator (PAM); NMDA-RECEPTOR; DISCOVERY; SERIES; SAR;
D O I
10.1016/j.bmcl.2015.10.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the optimization of a series of metabotropic glutamate receptor 5 (mGlu(5)) positive allosteric modulators (PAMs) from an acyl dihydropyrazolo[1,5-a]pyrimidinone class. Investigation of exocyclic amide transpositions with this unique 5,6-bicyclic core were conducted in attempt to modulate physicochemical properties and identify a suitable backup candidate with a reduced half-life. A potent and selective PAM, 1-(2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidin-4(5H)-yl) ethanone (9a, VU0462807), was identified with superior solubility and efficacy in the acute amphetamine-induced hyperlocomotion (AHL) rat model with a minimum effective dose of 3 mg/kg. Attempts to mitigate oxidative metabolism of the western phenoxy of 9a through extensive modification and profiling are described. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5115 / 5120
页数:6
相关论文
共 50 条
  • [1] Positive allosteric modulators of metabotropic glutamate receptor 5: A new generation of antipsychotics?
    Mutel, V
    Bessis, AS
    Epping-Jordan, M
    Le Poul, E
    Ludwig, B
    Poli, SM
    Rocher, JP
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S30 - S30
  • [2] Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5)
    Varnes, Jeffrey G.
    Marcus, Andrew P.
    Mauger, Russell C.
    Throner, Scott R.
    Hoesch, Valerie
    King, Megan M.
    Wang, Xia
    Sygowski, Linda A.
    Spear, Nathan
    Gadient, Reto
    Brown, Dean G.
    Campbell, James B.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1402 - 1406
  • [3] Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5)
    Williams, DL
    Lindsley, CW
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 825 - 846
  • [4] Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5
    Lakkaraju, Sirish K.
    Mbatia, Hannah
    Hanscom, Marie
    Zhao, Zaorui
    Wu, Junfang
    Stoica, Bogdan
    MacKerell, Alexander D., Jr.
    Faden, Alan I.
    Xue, Fengtian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (11) : 2275 - 2279
  • [5] Discovery of 1,5-Disubstituted Pyridones: A New Class of Positive Allosteric Modulators of the Metabotropic Glutamate 2 Receptor
    Maria Cid, Jose
    Duvey, Guillaume
    Cluzeau, Philippe
    Nhem, Vanthea
    Macary, Karim
    Raux, Alexandre
    Poirier, Nicolas
    Muller, Jessica
    Bolea, Christelle
    Finn, Terry
    Poli, Sonia
    Epping-Jordan, Mark
    Chamelot, Emilie
    Derouet, Francis
    Girard, Francoise
    Macdonald, Gregor J.
    Antonio Vega, Juan
    Isabel de Lucas, Ana
    Matesanz, Encarnacion
    Lavreysen, Hilde
    Lourdes Linares, Maria
    Oehlrich, Daniel
    Oyarzabal, Julen
    Tresadern, Gary
    Trabanco, Andres A.
    Ignacio Andres, Jose
    Le Poul, Emmanuel
    Imogai, Hassan
    Lutjens, Robert
    Rocher, Jean-Philippe
    ACS CHEMICAL NEUROSCIENCE, 2010, 1 (12): : 788 - 795
  • [6] A novel series of metabotropic glutamate receptor 5 negative allosteric modulators based on a 4,5,6,7-tetrahydropyrazolo [1,5-a]pyridine core
    Duvey, Guillaume
    Perry, Benjamin
    Le Poul, Emmanuel
    Poli, Sonia
    Bonnet, Beatrice
    Lambeng, Nathalie
    Charvin, Delphine
    Donovan-Rodrigues, Tansy
    Haddouk, Hasnaa
    Gagliardi, Stefania
    Rocher, Jean-Philippe
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (16) : 4523 - 4527
  • [7] Allosteric Modulators of Metabotropic Glutamate Receptor 5 for Treatment of Schizophrenia
    Conn, P. J.
    Stauffer, S. R.
    Zhou, S.
    Manka, J.
    Williams, R.
    Noetzel, M. J.
    Gregory, K. J.
    Vinson, P.
    Niswender, C. M.
    Jones, C. K.
    Steckler, T.
    MacDonald, G.
    Lindsley, C. W.
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 11 - 12
  • [8] Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia
    Fraley, Mark E.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1259 - 1275
  • [9] Progress in the Developement of Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 2
    Trabanco, A. A.
    Cid, J. M.
    Lavreysen, H.
    Macdonald, G. J.
    Tresadern, G.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (01) : 47 - 68
  • [10] Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGlu5)
    Stauffer, Shaun R.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (08): : 450 - 470